Logo image of SVMK

Svmk Inc (SVMK) Stock Fundamental Analysis

NASDAQ:SVMK - Nasdaq -

21.55  +0.26 (+1.22%)

After market: 21.55 0 (0%)

Fundamental Rating

2

Overall SVMK gets a fundamental rating of 2 out of 10. We evaluated SVMK against 283 industry peers in the Software industry. SVMK may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SVMK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SVMK has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -10.83%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -22.11%
PM (TTM) -24.89%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

SVMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.72 indicates that SVMK is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.61 indicates that SVMK is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 2.72
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.17 indicates that SVMK should not have too much problems paying its short term obligations.
SVMK has a Quick Ratio of 1.17. This is a normal value and indicates that SVMK is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17

More info and screens

5

3. Growth

3.1 Past

SVMK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
Looking at the last year, SVMK shows a quite strong growth in Revenue. The Revenue has grown by 19.14% in the last year.
The Revenue has been growing by 16.02% on average over the past years. This is quite good.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)19.14%
Revenue growth 3Y19.74%
Revenue growth 5Y16.02%
Sales Q2Q%15.9%

3.2 Future

The Earnings Per Share is expected to grow by 246.73% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.68% on average over the next years. This is quite good.
EPS Next Y400.9%
EPS Next 2Y325.75%
EPS Next 3Y234.95%
EPS Next 5Y246.73%
Revenue Next Year18.43%
Revenue Next 2Y19.12%
Revenue Next 3Y18.94%
Revenue Next 5Y18.68%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SVMK Yearly Revenue VS EstimatesSVMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
SVMK Yearly EPS VS EstimatesSVMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SVMK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 133.63, the valuation of SVMK can be described as expensive.
When comparing the Price/Forward Earnings ratio of SVMK to the average of the S&P500 Index (22.49), we can say SVMK is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 133.63
SVMK Price Earnings VS Forward Price EarningsSVMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -2000Q -4000Q -6000Q -8000Q -10000Q

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -77.78
SVMK Per share dataSVMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

SVMK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVMK's earnings are expected to grow with 234.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y325.75%
EPS Next 3Y234.95%

More info and screens

0

5. Dividend

5.1 Amount

SVMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Svmk Inc

NASDAQ:SVMK (6/14/2021, 8:00:01 PM)

After market: 21.55 0 (0%)

21.55

+0.26 (+1.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change-99.8%
Ins Owners5.21%
Ins Owner Change0%
Market Cap3.14B
Analysts90
Price Target27.43 (27.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 133.63
P/S 8.05
P/FCF N/A
P/OCF N/A
P/B 9.03
P/tB N/A
EV/EBITDA -77.78
EPS(TTM)0
EYN/A
EPS(NY)0.16
Fwd EY0.75%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.68
BVpS2.39
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.83%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -22.11%
PM (TTM) -24.89%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 2.72
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y400.9%
EPS Next 2Y325.75%
EPS Next 3Y234.95%
EPS Next 5Y246.73%
Revenue 1Y (TTM)19.14%
Revenue growth 3Y19.74%
Revenue growth 5Y16.02%
Sales Q2Q%15.9%
Revenue Next Year18.43%
Revenue Next 2Y19.12%
Revenue Next 3Y18.94%
Revenue Next 5Y18.68%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A